PCSA
NASDAQ
$2.22
Processa Pharmaceuticals Inc (PCSA)
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients with unmet medical needs in the United States. The company is headquartered in Hanover, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Target: $25 (+1026.13%)
Market Cap
$6.40M
FCF 5Y CAGR
+20.40%
Beta (5Y)
0.65
Price Chart
Valuation
Market Cap$6.40M
P/S1320.06
P/B2.53
Profitability
EBITDA-$14M
EPS-$6.63
Growth & Risk
EPS 5Y CAGR-22.78%
FCF 5Y CAGR+20.40%
Beta (5Y)0.65
Sharpe Ratio0.27